Cannabinoid dose and label accuracy in edible medical cannabis products

R. VANDREY ; J. C. RABER ; M. E. RABER ; B. DOUGLASS ; C. MILLER ; M. O. BONN-MILLER | 2015
Dans Journal of the American Medical Association (Vol.313, n°24, June 23/30, 2015) Article : Périodique

Regulation and quality assurance for edible product cannabinoid content and labeling are generally lacking. We investigated the label accuracy of edible cannabis products.

Plus d'info

Ajouter à la sélection

Cannabis withdrawal in adolescent treatment seekers

R. VANDREY ; A. J. BUDNEY ; J. L. KAMON ; C. STANGER | 2005
Dans Drug and Alcohol Dependence (Vol.78, n°2, May 2005) Article : Périodique

A valid cannabis withdrawal syndrome has been demonstrated in controlled studies with adult marijuana abusers, yet few published reports have examined cannabis withdrawal among adolescents. Adolescents presenting for outpatient substance abuse t[...]

Plus d'info

Ajouter à la sélection

Review of the validity and significance of cannabis withdrawal syndrome

A. J. BUDNEY ; J. R. HUGHES ; B. A. MOORE ; R. VANDREY | 2004
Dans American Journal of Psychiatry (Vol.161, n°11, November 2004) Article : Périodique

The authors review the literature examining the validity and significance of cannabis withdrawal syndrome. Findings from animal laboratory research are briefly reviewed, and human laboratory and clinical studies are surveyed in more detail. Conv[...]

Plus d'info

Ajouter à la sélection

Lien externe

A survey study to characterize use of Spice products (synthetic cannabinoids)

R. VANDREY ; K. E. DUNN ; J. A. FRY ; E. R. GIRLING | 2012
Dans Drug and Alcohol Dependence (Vol.120, n°1-3, January 2012) Article : Périodique

BACKGROUND: Synthetic cannabinoids are a rapidly emerging class of abused drugs. Synthetic cannabinoids are typically sold as "herbal blends" or "incense," commonly referred to as Spice products. No controlled human experiments have been conduct[...]

Plus d'info

Ajouter à la sélection

The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use [Addiction opinion and debate]

V. LORENZETTI ; C. HINDOCHA ; K. PETRILLI ; P. GRIFFITHS ; J. BROWN ; A. CASTILLO-CARNIGLIA ; J. P. CAULKINS ; A. ENGLUND ; M. A. ElSOHLY ; S. H. GAGE ; T. GROSHKOVA ; A. GUAL ; D. HAMMOND ; W. LAWN ; H. LOPEZ-PELAYO ; J. MANTHEY ; C. MOKRYSZ ; R. L. PACULA ; M. VAN LAAR ; R. VANDREY ; E. WADSWORTH ; A. WINSTOCK ; W. HALL ; H. V. CURRAN ; T. P. FREEMAN | 2022
Dans Addiction (Vol.117, n°6, June 2022) Article : Périodique

BACKGROUND: The lack of an agreed international minimum approach to measuring cannabis use hinders the integration of multidisciplinary evidence on the psychosocial, neurocognitive, clinical and public health consequences of cannabis use. METH[...]

Plus d'info

Ajouter à la sélection

Lien externe